PG
CTSO icon

PEAK6 Group’s Cytosorbents Corp CTSO Stock Holding History

PEAK6 Group’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$168K Buy
+14,737
New +$140K ﹤0.01% 3446
2018
Q1 		– Sell
-99,744
Closed -$648K – 4417
2017
Q4 		$648K Buy
99,744
+25,122
+34% +$160K ﹤0.01% 2264
2017
Q3 		$463K Buy
74,622
+53,391
+251% +$272K ﹤0.01% 2605
2017
Q2 		$91K Buy
21,231
+3,231
+18% +$14.2K ﹤0.01% 3894
2017
Q1 		$81K Buy
+18,000
New +$101K ﹤0.01% 3680
2015
Q4 		– Sell
-11
Closed – – 4832
2015
Q3 		$0 Buy
+11
New +$73 ﹤0.01% 5183

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

PEAK6 Group's CTSO Position: Q2 2018 in Review

PEAK6 Group opened a new position in Cytosorbents Corp (CTSO) in Q2 2018: 14,737 shares worth $168K. The stake represents ﹤0.01% of the portfolio and ranks #3446 among its holdings. This is a return to the name: PEAK6 Group previously reported a position in CTSO as recently as Q4 2017.

PEAK6 Group first reported a position in CTSO in Q3 2015 and has held it in 6 quarters since. The position peaked at $648K in Q4 2017. 75 funds tracked by Wall St. Rank hold CTSO as of Q2 2018.

  • PEAK6 Group held 14,737 shares of Cytosorbents Corp worth $168K as of Q2 2018.
  • Cytosorbents Corp was a new PEAK6 Group position in Q2 2018.
  • Cytosorbents Corp made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #3446 holding.
  • PEAK6 Group first reported a position in Cytosorbents Corp in Q3 2015 and has held it in 6 quarters since.
  • PEAK6 Group's Cytosorbents Corp position peaked at $648K in Q4 2017.
  • 75 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.